Innate immunity evasion by Dengue virus

Area of Science:

• Virology
• Immunology
• Infectious Diseases

Background:

• Viruses must overcome host innate immunity, particularly type I interferon (IFN) responses, for productive infection.
• Type I IFN responses are crucial for adaptive immunity development against viral infections.
• Dengue virus (DENV) actively inhibits both type I IFN production and signaling pathways in host cells.

Purpose of the Study:

• To review the mechanisms by which DENV evades innate immunity.
• To evaluate the role of DENV's innate immune evasion strategies in viral pathogenesis.
• To assess the contribution of innate immunity evasion to DENV's host tropism.

Main Methods:

• Review of existing literature on DENV-host interactions.
• Analysis of DENV protein functions in inhibiting type I IFN pathways.
• Examination of the impact of DENV immune evasion on disease and host range.

Main Results:

• DENV's NS2B3 protease complex inhibits type I IFN production via its proteolytic activity.
• DENV proteins NS2A, NS4A, NS4B, and NS5 antagonize type I IFN signaling by targeting pathway components like STATs.
• DENV NS5 protein's interaction with STAT2 limits DENV's host tropism to humans and non-human primates.

Conclusions:

• DENV employs multiple strategies to suppress type I IFN immunity.
• Inhibition of type I IFN responses is critical for DENV pathogenesis.
• DENV's evasion of innate immunity, particularly STAT2 degradation by NS5, shapes its host tropism.